Median seizure reduction was substantially greater after nine years of therapy than after three years, reveals a long-term prospective study of the implantable RNS neuromodulation system.
The new deep brain stimulation system for epilepsy seems best suited to patients whose seizures are hard to localize or restrict to just a couple brain regions. We share insights as one of the initial U.S. treating sites.
Closed-loop stimulation is a breakthrough that has great potential for helping patients manage their pain.
Here’s a status update from this historic trial, including a rundown of elements being investigated in addition to stroke survivors’ functional outcomes.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A case vignette offers insights into the virtues — and mechanics — of a new minimally invasive neuromodulation option for neuropathic limb pain.
Findings of this milestone investigation suggest that analgesia may not be the appropriate therapy goal in central pain syndromes and that neuromodulation should focus on pain-related suffering and disability.
A scientist involved in Cleveland Clinic’s newly launched study of neuromodulation for post-stroke recovery speaks to the science behind the trial and the NIH BRAIN grant supporting this work.
For the first time, deep brain stimulation electrodes have been implanted in a stroke survivor to restore lost motor function. The aim is to boost rehabilitation beyond what physical therapy can do alone.
The first-in-human trial of neuromodulation for rehabilitative therapy in stroke survivors has been given a boost with a $5 million grant. The lead investigator explains the study’s goals and rationale.
Cleveland Clinic Neurological Institute investigators are hoping that deep brain stimulation (DBS) will prove effective in helping patients regain motor function lost to a stroke.